Activist Investor 13D Filings


This table shows recent activist investor (Schedule 13D) filings made in this industry. Any investor or hedge fund that makes an investment with the intention of influencing management is considered an activist investor and must file a 13D.

DateFormInvestorTargetSharesOwnership
(Percent)
Ownership Change
(Percent)
2018‑07‑13 SC 13D/A Eastern Capital LTD IBIO / iBio 8,498,512 48.0 -4.87
2018‑07‑12 SC 13D/A AISLING CAPITAL III LP LOXO / Loxo Oncology 2,038,920 6.8 -44.73
2018‑07‑11 SC 13D/A LFB Biotechnologies S.A.S.U. TGTX / TG Therapeutics 2,614,855 3.4 -65.66
2018‑07‑10 SC 13D/A MacAndrews & Forbes Inc. VTVT / vTv Therapeutics 28,181,305 79.8 0.00
2018‑07‑10 SC 13D/A Growth Equity Opportunities IV, LLC AVEO / AVEO Pharmaceuticals 28,146,416 21.8 5.32
2018‑07‑03 SC 13D/A Satter Muneer A AKBA / Akebia Therapeutics 3,067,043 5.4 0.41
2018‑07‑03 SC 13D Peizer Terren S BIVI / BioVie 400,833,333 80.3
2018‑07‑02 SC 13D Liu Waiping BSPM / Biostar Pharmaceuticals 426,999 16.2
2018‑07‑02 SC 13D/A Healios K.k. ATHX / Athersys 16,000,000 11.3 0.00
2018‑06‑29 SC 13D White Winston Select Asset Fund Series Fund Mp-18, Llc MSLP / MusclePharm 2,927,677 19.87
2018‑06‑29 SC 13D/A Invus, L.P. LXRX / Lexicon Pharmaceuticals 60,240,864 56.9 2.10
2018‑06‑29 SC 13D/A Baupost Group LLC/MA KERX / Keryx Biopharmaceuticals 61,374,013 39.35 0.00
2018‑06‑28 SC 13D/A Eastern Capital LTD IBIO / iBio 8,933,512 48.0 -80.47
2018‑06‑28 SC 13D/A Sagard Capital Partners, L.P. JAGX / Jaguar Animal Health 3,314,956 22.5 -93.33
2018‑06‑27 SC 13D Pontifax Management 4 G.p. (2015) Ltd. ARQL / ArQule 2,238,000 8.8
2018‑06‑27 SC 13D EdgePoint Investment Group Inc. NVLN / NOVELION THERAPEUTICS 2,456,064 7.32 0.28
2018‑06‑26 SC 13D/A BFI Co., LLC PAHC / Phibro Animal Health 204,255,041 50.7 -1.03
2018‑06‑22 SC 13D/A Sarissa Capital Management LP APRI / Apricus Biosciences
2018‑06‑21 SC 13D/A Biotechnology Value Fund L P INFI / Infinity Pharmaceuticals 15,232,268 27.2 35.08
2018‑06‑20 SC 13D/A MacAndrews & Forbes Inc. VTVT / vTv Therapeutics 28,181,305 79.8 0.00
2018‑06‑19 SC 13D/A WILCOX GARY COCP / Cocrystal Pharma 10,361,985 34.48
2018‑06‑18 SC 13D Akkaraju Srinivas VSAR / Versartis, Inc.. 2,682,554 7.4
2018‑06‑18 SC 13D/A LFB Biotechnologies S.A.S.U. TGTX / TG Therapeutics 7,614,855 9.8 0.00
2018‑06‑15 SC 13D Roivant Sciences Ltd. AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑14 SC 13D Groman John E VNTH / Nano Mobile Healthcare 1,387,363 37.82 -93.93
2018‑06‑14 SC 13D Finnegan Cara Marie VNTH / Nano Mobile Healthcare 457,500 26.2
2018‑06‑14 SC 13D Swan Allison Carol VNTH / Nano Mobile Healthcare 13,063 9.99
2018‑06‑11 SC 13D/A SMITH CLARENCE EDWARD PKTX / ProtoKinetix 75,880,942 28.3 5.06
2018‑06‑11 SC 13D/A Healios K.k. ATHX / Athersys 16,000,000 11.3 33.33
2018‑06‑08 SC 13D/A Satter Muneer A VTL / Vital Therapies 11,597,719 27.2 5.10
2018‑06‑07 SC 13D/A Svf Investments (uk) Ltd AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑07 SC 13D/A QVT Financial LP AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑07 SC 13D/A Lo Andrew AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑07 SC 13D/A Dexxon Holdings Ltd. AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑07 SC 13D/A Machado Patrick AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑05 SC 13D/A ACCESS INDUSTRIES MANAGEMENT, LLC LOXO / Loxo Oncology 857,982 2.85 -50.73
2018‑06‑05 SC 13D/A New Enterprise Associates 12, Limited Partnership ARDX / Ardelyx 16,736,044 27.2 8.07
2018‑06‑04 SC 13D/A Invus, L.P. LXRX / Lexicon Pharmaceuticals 59,002,706 55.8
2018‑05‑31 SC 13D/A Vatera Holdings Llc MLNT / Melinta Therapeutics 16,607,959 29.7
2018‑05‑29 SC 13D/A MacAndrews & Forbes Inc. VTVT / vTv Therapeutics 28,181,305 79.8 0.18
2018‑05‑25 SC 13D/A Invesco Ltd. EVFM / Evofem Biosciences 9,590,688 35.94
2018‑05‑24 SC 13D/A THREE ARCH PARTNERS IV LP ACRX / AcelRx Pharmaceuticals 0 0.0 -100.00
2018‑05‑23 SC 13D Growth Equity Opportunities V, LLC MEIP / MEI Pharma 7,025,641 9.99
2018‑05‑22 SC 13D/A Starboard Value LP DEPO / DepoMed 2,703,995 4.3 -30.40
2018‑05‑21 SC 13D/A Broadfin Capital, LLC BDSI / BioDelivery Sciences International 4,278,819 7.2 0.00
2018‑05‑21 SC 13D/A Engaged Capital LLC PETX / Aratana Therapeutics 2,400,000 5.1 0.00
2018‑05‑18 SC 13D/A Bp Peptides, Llc CAPS / Capstone Therapeutics 20,488,518 36.4 4.93
2018‑05‑17 SC 13D Op Financial Ltd NBY / NovaBay Pharmaceuticals 1,700,000 9.9
2018‑05‑17 SC 13D/A ARMISTICE CAPITAL, LLC EYEG / Eyegate Pharmaceuticals 16,742,500 40.2 3.05
2018‑05‑16 SC 13D/A Eastern Capital LTD TPIV / TapImmune 5,300,002 38.8 32.50